SCHEMBL19784554

SCHEMBL19784554

CCC(=O)OCS(Cl)(Cl)Cl

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NAAA Q02083 1/20 0.41
SOAT1 P35610 1/20 0.40
ALDH1A1 P00352 6/20 0.38
CYP1A2 P05177 1/20 0.38
HPGD P15428 1/20 0.38
CYP2C19 P33261 1/20 0.38
BLM P54132 1/20 0.38
WRN Q14191 1/20 0.38
HIF1A Q16665 1/20 0.38
GAA P10253 2/20 0.35
MGAM O43451 1/20 0.35
SI P14410 1/20 0.35
MGAM2 Q2M2H8 1/20 0.35
TRPA1 O75762 1/20 0.32
HTT P42858 1/20 0.31
LMNA P02545 1/20 0.31
HSD17B10 Q99714 1/20 0.31
TDP1 Q9NUW8 2/20 0.30
FFAR3 O14843 1/20 0.30
KDM4E B2RXH2 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19784713 0.83 NAAA (0.40) NAAASOAT1ALDH1A1CYP1A2HPGD
SCHEMBL20299318 0.83 NAAA (0.40) NAAASOAT1ALDH1A1CYP1A2HPGD
SCHEMBL230663 0.76
SCHEMBL11208718 0.75 NAAA (0.41) NAAASOAT1ALDH1A1CYP1A2HPGD
SCHEMBL28082607 0.75 NAAA (0.41) NAAASOAT1ALDH1A1CYP1A2HPGD
SCHEMBL28082406 0.73 NAAA (0.40) NAAASOAT1ALDH1A1CYP1A2HPGD
Ammonia Solution, Strong SCHEMBL28082724 0.73 NAAA (0.40) NAAASOAT1ALDH1A1CYP1A2HPGD
SCHEMBL28082443 0.73 NAAA (0.40) NAAASOAT1ALDH1A1CYP1A2HPGD
SCHEMBL30705379 0.73 NAAA (0.40) NAAASOAT1ALDH1A1CYP1A2HPGD
SCHEMBL28082642 0.73 NAAA (0.40) NAAASOAT1ALDH1A1CYP1A2HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240222629-A1 SECONDARY BATTERY AND MANUFACTURING METHOD THEREOF SEMICONDUCTOR ENERGY LAB (JP) 2024-07-04 US disclosed
US-20210104744-A1 SECONDARY BATTERY AND MANUFACTURING METHOD THEREOF SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2021-04-08 US disclosed
US-20180076489-A1 ELECTRODE AND POWER STORAGE DEVICE SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2018-03-15 US disclosed
US-20180019462-A1 Graphene Compound, Method for Forming Graphene Compound, and Power Storage Device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2018-01-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180076489-A1 ELECTRODE AND POWER STORAGE DEVICE SELENOI, SOD1, L1CAM NAAA 740/4885SOAT1 903/4885ALDH1A1 2875/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.